Screener
Akebia Therapeutics AKBA Q4 2025 Annual earnings
Reported February 26, 2026 · Before market open
Revenue$57.6MBeat by $11.5M
EPS-$0.05Miss by $0.02
Revenue estimate$46.1M
EPS estimate-$0.03
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$46.9M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Akebia Therapeutics report Q4 2025 earnings?
- Akebia Therapeutics (AKBA) reported Q4 2025 earnings on February 26, 2026 before market open.
- What were Akebia Therapeutics's Q4 2025 revenue and EPS?
- Akebia Therapeutics reported revenue of $57.6M and eps of $-0.05 for Q4 2025.
- Did Akebia Therapeutics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $46.1M by $11.5M. EPS missed the consensus estimate of $-0.03 by $0.02.
- How did Akebia Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 23.9% from $46.5M a year earlier and eps grew 50.0% from $-0.10.
- Where can I find Akebia Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001517022-26-000019) and the 10-K periodic report (0001517022-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.
